| Followers | 96 |
| Posts | 5080 |
| Boards Moderated | 0 |
| Alias Born | 02/07/2021 |
Wednesday, January 15, 2025 10:49:33 AM
Advent BioServices' only value add are the highly technical personnel on their payroll. They hold no IP, own zero equipment, cannot transfer or apply for an MIA without IP and equipment needed for operating the CDMO. We have contracts with them they cannot simlply nullify as that isn't how contracts work. The structure works well as Northwest Biotherapeutics has not had to take on even more dilution or debt to fund their payroll which would likely make our burn rate well over $10M per month.
You simply like to manufacture BS while Advent are manufacturing life-saving vaccines. Telling! I can't wait to see how many more posts on this site have been catalogued by Cohen Milstein in their spoofing lawsuit. There's an obvious effort to discredit the company at every achieved milestone. I am buying more on Friday.
You simply like to manufacture BS while Advent are manufacturing life-saving vaccines. Telling! I can't wait to see how many more posts on this site have been catalogued by Cohen Milstein in their spoofing lawsuit. There's an obvious effort to discredit the company at every achieved milestone. I am buying more on Friday.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM

